Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch

Hum Mol Genet. 2000 Jan 1;9(1):69-78. doi: 10.1093/hmg/9.1.69.

Abstract

Machado-Joseph disease (MJD) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine stretch in the MJD gene-encoded protein, ataxin-3. Using a series of deletion constructs expressing ataxin-3 fragments with expanded polyglutamine stretches, we observed aggregate formation and cell death in cultured BHK-21 cells. The cytotoxic effect of N-terminal-truncated ataxin-3 with the expanded polyglutamine tract was enhanced under serum starvation culture, in which cells were arrested in the G(0)/G(1)phase. Coexpression of p21 (waf1/cip1/sdi1), a cyclin-Cdk inhibitor that induced cell cycle arrest in the G(1)phase, also increased the cell death susceptibility produced by the mutant ataxin-3 fragment in BHK-21 cells. The elevated susceptibility to cell death in the G(0)/G(1)phase was confirmed in nerve growth factor-treated, postmitotic neuronal PC12 cells compared with undifferentiated proliferating PC12 cells. These results strongly suggest that the cellular toxicity of truncated ataxin-3 with an expanded polyglutamine stretch is enhanced by cell cycle arrest in the G(0)/G(1)phase. Mutant ataxin-3 may confer a higher susceptibility to cell death on cells in the G(0)/G(1)phase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ataxin-3
  • Base Sequence
  • Cell Cycle / genetics*
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Line
  • Cricetinae
  • Culture Media, Serum-Free
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / genetics
  • Cyclins / metabolism
  • Enzyme Inhibitors / metabolism
  • Humans
  • Machado-Joseph Disease / genetics*
  • Molecular Sequence Data
  • Mutation*
  • Nerve Growth Factor / pharmacology
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / metabolism*
  • Nuclear Proteins
  • Peptides / genetics
  • Pheochromocytoma / drug therapy
  • Pheochromocytoma / genetics
  • Pheochromocytoma / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Repressor Proteins

Substances

  • CDKN1A protein, human
  • Culture Media, Serum-Free
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Enzyme Inhibitors
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Peptides
  • Recombinant Proteins
  • Repressor Proteins
  • polyglutamine
  • Nerve Growth Factor
  • ATXN3 protein, human
  • Ataxin-3